Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| VTRS | Viatris Inc | 2025-10-16 20:16:38 | 10.18 | 0.08 | 0.79 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VTRS | 0001792044 | Viatris Inc | US92556V1061 | 254900ZZTSW7NL773X71 | 834364296 | Nasdaq | 2834 | Pharmaceutical Preparations | 1231 | DE | 1000 MYLAN BOULEVARD | CANONSBURG | PA | 15317 | UNITED STATES | US | (724) 514-1465 | 1000 MYLAN BOULEVARD, CANONSBURG, PA, 15317 | 1000 MYLAN BOULEVARD, CANONSBURG, PA, 15317 | Upjohn Inc | Pharmaceuticals | 2020-11-16 | Scott A. Smith | 32,000 | http://viatris.com | 12,661,582,065 | 100 | 1,165,872,127 | Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. | 2025-10-10 19:42:52 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 12,661,582,065 | 724,869,483 | 6.0726 | 1,185,856,452 | -4,805,947 | -0.4036 |
| 2023 | 11,936,712,582 | -725,415,409 | -5.729 | 1,190,662,399 | -8,345,782 | -0.6961 |
| 2022 | 12,662,127,991 | -4,575,609,222 | -26.5441 | 1,199,008,181 | -13,293,060 | -1.0965 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Rajiv Malik | President | 2023 | 1,298,077 | 0 | 7,800,015 | 2,962,538 | 423,045 | 12,483,675 |
| Anthony Mauro | President | 2023 | 858,846 | 0 | 3,440,016 | 1,803,046 | 333,496 | 6,435,404 |
| Scott A. Smith | Chief Executive Officer | 2023 | 1,023,077 | 0 | 11,200,008 | 2,884,494 | 822,830 | 15,930,409 |
| Sanjeev Narula | Chief Financial Officer | 2023 | 923,558 | 0 | 3,700,013 | 1,686,368 | 470,303 | 6,780,242 |
| Brian Roman | General Counsel | 2023 | 790,385 | 0 | 1,600,015 | 1,458,480 | 263,253 | 4,112,133 |
| Fiscal Year | Employee Count |
|---|---|
| 2020 | 45,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 14,739,300,000 | 15,426,900,000 | 16,262,700,000 |
| Cost Of Revenue | 9,115,700,000 | 8,988,300,000 | 9,765,700,000 |
| Gross Profit | 5,623,600,000 | 6,438,600,000 | 6,497,000,000 |
| Research And Development Expenses | 808,700,000 | 805,200,000 | 662,200,000 |
| General And Administrative Expenses | 4,425,600,000 | 4,650,100,000 | 4,179,100,000 |
| Operating Expenses | 5,613,500,000 | 5,672,400,000 | 4,882,100,000 |
| Operating Income | 10,100,000 | 766,200,000 | 1,614,900,000 |
| Net Income | -634,200,000 | 54,700,000 | 2,078,600,000 |
| Earnings Per Share Basic | -0.53 | 0.05 | 1.71 |
| Earnings Per Share Diluted | -0.53 | 0.05 | 1.71 |
| Weighted Average Shares Outstanding Basic | 1,196,603,773 | 1,094,000,000 | 1,212,100,000 |
| Weighted Average Shares Outstanding Diluted | 1,196,603,773 | 1,094,000,000 | 1,217,400,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 734,800,000 | 991,900,000 | 1,259,900,000 |
| Marketable Securities Current | 38,000,000 | 37,000,000 | 35,300,000 |
| Accounts Receivable | 2,675,300,000 | 2,823,800,000 | 3,243,800,000 |
| Inventories | 3,854,100,000 | 3,469,700,000 | 3,519,500,000 |
| Non Trade Receivables | 300,700,000 | 340,200,000 | — |
| Other Assets Current | 387,200,000 | 271,000,000 | 1,404,000,000 |
| Total Assets Current | 9,520,700,000 | 12,976,100,000 | 10,635,400,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 2,666,100,000 | 2,759,600,000 | 3,024,500,000 |
| Other Assets Non Current | 2,356,900,000 | 2,208,700,000 | 2,403,500,000 |
| Total Assets Non Current | 31,980,200,000 | 34,709,400,000 | 39,386,800,000 |
| Total Assets | 41,500,900,000 | 47,685,500,000 | 50,022,200,000 |
| Accounts Payable | 1,853,700,000 | 1,938,200,000 | 1,766,600,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 600,000 | 1,934,700,000 | 1,250,500,000 |
| Other Liabilities Current | 3,724,700,000 | 3,393,900,000 | 3,440,900,000 |
| Total Liabilities Current | 5,779,400,000 | 7,777,400,000 | 6,746,200,000 |
| Long Term Debt | 14,038,900,000 | 16,188,100,000 | 18,015,200,000 |
| Other Liabilities Non Current | 1,939,200,000 | 1,516,900,000 | 1,756,500,000 |
| Total Liabilities Non Current | 17,086,000,000 | 19,440,700,000 | 22,203,700,000 |
| Total Liabilities | 22,865,400,000 | 27,218,100,000 | 28,949,900,000 |
| Common Stock | 12,300,000 | 12,200,000 | 12,100,000 |
| Retained Earnings | 3,418,800,000 | 4,639,700,000 | 5,175,600,000 |
| Accumulated Other Comprehensive Income | -3,212,900,000 | -2,747,400,000 | -2,761,200,000 |
| Total Shareholders Equity | 18,635,500,000 | 20,467,400,000 | 21,072,300,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 2,536,100,000 | 2,349,100,000 | 2,678,100,000 |
| Share Based Compensation Expense | 146,100,000 | 180,700,000 | 116,400,000 |
| Other Non Cash Income Expense | -297,700,000 | -595,400,000 | -434,300,000 |
| Change In Accounts Receivable | -300,100,000 | -78,600,000 | 240,300,000 |
| Change In Inventories | 723,400,000 | 613,300,000 | 259,500,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 36,000,000 | 314,700,000 | 170,200,000 |
| Change In Other Liabilities | 150,600,000 | 414,600,000 | 618,300,000 |
| Cash From Operating Activities | 2,302,900,000 | 2,799,600,000 | 2,952,600,000 |
| Purchases Of Marketable Securities | 26,000,000 | 26,300,000 | 30,200,000 |
| Sales Of Marketable Securities | 26,000,000 | 26,300,000 | 29,900,000 |
| Acquisition Of Property Plant And Equipment | 326,000,000 | 377,000,000 | 406,000,000 |
| Acquisition Of Business | 350,000,000 | 667,700,000 | 0 |
| Other Investing Activities | 20,800,000 | 97,500,000 | 37,000,000 |
| Cash From Investing Activities | 1,800,700,000 | -764,100,000 | 1,520,500,000 |
| Tax Withholding For Share Based Compensation | 53,300,000 | 38,200,000 | 17,300,000 |
| Payments Of Dividends | 586,700,000 | 590,600,000 | 591,800,000 |
| Issuance Of Common Stock | 2,500,000 | 3,100,000 | 3,300,000 |
| Repurchase Of Common Stock | 250,000,000 | 250,000,000 | — |
| Issuance Of Long Term Debt | 0 | 300,000 | 1,875,600,000 |
| Repayment Of Long Term Debt | 3,713,700,000 | 1,250,200,000 | 3,662,500,000 |
| Other Financing Activities | 295,200,000 | -173,000,000 | 18,600,000 |
| Cash From Financing Activities | -4,330,400,000 | -2,301,900,000 | -3,877,900,000 |
| Change In Cash | -257,500,000 | -268,900,000 | 556,300,000 |
| Cash At End Of Period | 734,800,000 | 991,900,000 | 1,259,900,000 |
| Income Taxes Paid | 514,000,000 | 570,900,000 | 735,200,000 |
| Interest Paid | 561,100,000 | 611,600,000 | 642,500,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | -0.53 | 0.05 | 1.71 |
| Price To Earnings Ratio | -23.4906 | 216.6 | 6.5088 |
| Earnings Growth Rate | -1,160 | -97.076 | -262.8571 |
| Price Earnings To Growth Ratio | 0.0203 | -2.2312 | -0.0248 |
| Book Value Per Share | 15.5737 | 18.7088 | 17.385 |
| Price To Book Ratio | 0.7994 | 0.5789 | 0.6402 |
| Ebitda | 2,965,900,000 | 3,547,800,000 | 6,084,300,000 |
| Enterprise Value | 28,202,416,973.85 | 28,978,920,000 | 31,496,473,000 |
| Dividend Yield | 0.0394 | 0.0498 | 0.0439 |
| Dividend Payout Ratio | -0.9251 | 10.7971 | 0.2847 |
| Debt To Equity Ratio | 0.7534 | 0.8854 | 0.9143 |
| Capital Expenditures | 2,442,600,000 | 2,084,200,000 | 2,514,000,000 |
| Free Cash Flow | -139,700,000 | 715,400,000 | 438,600,000 |
| Return On Equity | -0.034 | 0.0027 | 0.0986 |
| One Year Beta | 0.5579 | 0.8111 | 0.816 |
| Three Year Beta | 0.7622 | 0.7985 | 0.8048 |
| Five Year Beta | 0.7652 | 0.8034 | 0.8048 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Le Goff Corinne | Chief Commercial Officer | 2025-09-11 | 7,032 | D | 35,299 |
| Enrietti Andrew | — | 2025-08-15 | 75,401 | A | 75,401 |
| Smith Scott Andrew | Director, Chief Executive Officer | 2025-08-12 | 22,000 | A | 314,807 |
| SIMMONS DAVID S | Director | 2025-08-11 | 22,820 | A | 22,820 |
| SEVERINO MICHAEL | Director | 2025-05-12 | 25,112 | A | 25,112 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Thomas H Tuberville | Senator | 2022-09-15 | Sale (Full) | 2022-08-01 | Self | $1,001 - $15,000 |
| Thomas H Tuberville | Senator | 2022-02-14 | Sale (Full) | 2022-01-13 | Joint | $1,001 - $15,000 |
| Thomas R Carper | Senator | 2021-01-07 | Sale (Full) | 2020-12-30 | Spouse | $1,001 - $15,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Rob Bresnahan | 2025-05-08 | PA08 | Sale | 2025-04-08 | — | $1,001 - $15,000 |
| Gilbert Cisneros | 2025-04-07 | CA31 | Sale (Partial) | 2025-03-31 | — | $1,001 - $15,000 |
| Rob Bresnahan | 2025-03-27 | PA08 | Purchase | 2025-02-25 | — | $1,001 - $15,000 |
| Daniel Goldman | 2023-05-19 | NY10 | Sale (Partial) | 2023-04-10 | — | $1,001 - $15,000 |
| Daniel Goldman | 2023-04-17 | NY10 | Sale (Partial) | 2023-03-06 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Darwin Wealth Management, LLC | 2025-09-30 | 871 | 88 | 9.8977 |
| Lowe Wealth Advisors, LLC | 2025-09-30 | 149 | 15 | 9.9333 |
| HALBERT HARGROVE GLOBAL ADVISORS, LLC | 2025-09-30 | 426 | 43 | 9.907 |
| BEACON INVESTMENT ADVISORY SERVICES, INC. | 2025-09-30 | 445,213 | 44,971 | 9.9 |
| Capital Advisors, Ltd. LLC | 2025-09-30 | 16,000 | 1,651 | 9.6911 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| TRUST FOR PROFESSIONAL MANAGERS | 2025-08-31 | Column Mid Cap Fund | CFMCX | 33,435 | 352,739.25 | 0.0354 |
| Pacer Funds Trust | 2025-07-31 | Pacer US Small Cap Cash Cows ETF | CALF | 8,820,538 | 77,091,502.12 | 1.9263 |
| Pacer Funds Trust | 2025-07-31 | Pacer Trendpilot US Large Cap ETF | PTLC | 73,922 | 646,078.28 | 0.0194 |
| Pacer Funds Trust | 2025-07-31 | Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF | QDPL | 21,465 | 187,604.1 | 0.0172 |
| Pacer Funds Trust | 2025-07-31 | Pacer CFRA-Stovall Equal Weight Seasonal Rotation ETF | SZNE | 14,481 | 126,563.94 | 0.8321 |